Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease

NO_LONGER_AVAILABLE

Conditions studied: Crohn's Disease

In brief

Protocol 620 provides PROCHYMAL(R) adult human mesenchymal cells to specifically chosen Crohn's disease patients at participating centers who typically have already demonstrated good response in another PROCHYMAL study, are not eligible for other PROCHYMAL studies, and in the view of the investigator, would not benefit significantly from other Crohn's therapies but would benefit from use of PROCHYMAL. The study is not placebo-controlled or randomized.

Key facts

Study ID

NCT01510431

Run by

Mesoblast, Inc.

Last updated by the study team

2020-03-10

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• currently active moderate-to-severe Crohn's disease
• exhausted standard-of-care options
• age 18 to 70 inclusive
• body weight between 30 and 150 kg
• adequate renal function
• not at risk for tuberculosis (TB) activation or re-activation

You may not qualify if…

• biologic therapy for Crohn's within last 8 weeks
• confirmed adverse reactions during prior PROCHYMAL study participation
• alcohol or substance abuse, current or within past 6 months
• active HIV or hepatitis B or C infection
• surgery or trauma with 6 weeks
• allergy to bovine or porcine products
• elevated serum liver enzymes
• elevated serum bilirubin
• active malignancy within 5 years (other than some resected skin cancers)
• bacteremia or other serious bacterial or fungal infection within 3 months
• colonic dysplasia
• unstable arrhythmia or serious heart condition

Where it is running

• Unviersity of California, San Francisco — San Francisco, California, United States
• Stormont-Vail — Topeka, Kansas, United States
• Mount Sinai Hospital — New York, New York, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.